Aspen Pharmacare Total Assets 2017-2024 | APNHY

Aspen Pharmacare total assets from 2017 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Aspen Pharmacare Annual Total Assets
(Millions of US $)
2024 $7,445
2023 $7,574
2022 $7,328
2021 $7,151
2020 $8,576
2019 $8,623
2018 $10,374
2017 $8,548
2016 $7,238
2015 $0
Aspen Pharmacare Quarterly Total Assets
(Millions of US $)
2024-06-30 $7,445
2023-06-30 $7,574
2022-12-31 $6,849
2022-06-30 $7,328
2021-12-31 $7,627
2021-06-30 $7,151
2020-12-31 $7,974
2020-06-30 $8,576
2019-06-30 $8,623
2018-12-31 $9,424
2018-06-30 $10,374
2017-12-31 $9,004
2017-06-30 $8,548
2016-12-31 $7,762
2016-06-30 $7,238
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $2.392B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.477B 5.66
Dr Reddy's Laboratories (RDY) India $11.411B 21.77
BridgeBio Pharma (BBIO) United States $6.430B 0.00
Bausch Health Cos (BHC) Canada $1.876B 1.36
Supernus Pharmaceuticals (SUPN) United States $1.717B 16.02
Amphastar Pharmaceuticals (AMPH) United States $1.109B 6.71
Personalis (PSNL) United States $0.282B 0.00
Taysha Gene Therapies (TSHA) United States $0.254B 0.00
Assembly Biosciences (ASMB) United States $0.075B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.003B 0.00
Teligent (TLGT) United States $0.000B 0.00